Fullmektig i Norge:
Fullmektig i EP:
2017.07.14, JP 2017137678
BARLIND, JONAS G. et al.: "Identification and design of a novel series of MGAT2 inhibitors", Bioorganic & Medicinal Chemistry Letters, vol. 23, 2013, pages 2721-2726, XP028546942, (B1)
WO-A2-2015/191681 (B1)
CAROLYN L. LADD ET AL: "Intramolecular sp 3 Functionalization of Cyclopropyl [alpha]-Amino Acid-Derived Benzamides", JOURNAL OF ORGANIC CHEMISTRY, vol. 81, no. 1, 4 January 2016 (2016-01-04), pages 256-264, XP055762112, Japan ISSN: 0022-3263, DOI: 10.1021/acs.joc.5b01916 (B1)
CN-A- 103 012 397 (B1)
CN-A- 104 109 160 (B1)
JP-A- 2006 514 043 (B1)
JP-A- 2013 067 595 (B1)
JP-A- 2013 515 729 (B1)
JP-A- 2014 005 245 (B1)
JP-A- 2014 009 165 (B1)
JP-A- 2014 506 907 (B1)
JP-A- 2014 526 545 (B1)
JP-A- 2015 535 848 (B1)
JP-A- 2016 164 154 (B1)
JP-A- 2016 514 116 (B1)
JP-A- 2016 537 369 (B1)
JP-A- 2017 508 779 (B1)
KR-A- 20100 097 077 (B1)
LIPING H. PETTUS ET AL: "Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase Inhibitors", JOURNAL OF MEDICINAL CHEMISTRY, vol. 59, no. 13, 14 July 2016 (2016-07-14) , pages 6407-6430, XP055761979, ISSN: 0022-2623, DOI: 10.1021/acs.jmedchem.6b00610 (B1)
MA, ZHENGPING et al.: "Characterization of monoacylglycerol a cyltransferase 2 inhibitors by a novel probe in binding assays", Analytical Biochemistry, vol. 501, 2016, pages 48-55, XP029497221, (B1)
OKUMA, CHIHIRO et al.: "JTP-103237, a novel monoacylglycerol acyltransferase inhibitor, modulates fat absorption and prevents diet-induced obesity", European Journal of Pharmacology, vol. 758, 2015, pages 72-81, XP029221741, (B1)
Peter Stanetty ET AL: "New Benzo-and Thieno-fused Spirolactams", Acta Chim. Slov, 1 January 2009 (2009-01-01), pages 513-520, XP055762022, Retrieved from the Internet: URL:http://acta-arhiv.chem-soc.si/56/56-03 -513.pdf (B1)
SATO, KENJIRO et al.: "Discovery of a Novel Series of N-Phenylindoline-5-sulfonamide Derivatives as Potent, Selective, an d Orally Bioavailable Acyl CoA:Monoacylglycerol Acyltransfer ase-2 Inhibitors", Journal of Medicinal Chemistry, vol. 58, 2015, pages 3892-3909, XP055569872, (B1)
SATO, KENJIRO et al.: "Optimization of a novel series of N-ph enylindoline-5-sulfonamide-based acyl CoA:monoacylglycerol a cyltransferase-2 inhibitors: Mitigation of CYP3A4 time-dependent inhibition and phototoxic liabilities", Bioorganic & Medicinal Chemistry, vol. 23, 2015, pages 4544-4560, XP055571227, (B1)
STEVEN GUNAWAN ET AL: "Bifunctional building blocks in the Ugi-azide condensation reaction: a general strategy toward exploration of new molecular diversity", ORGANIC & BIOMOLECULAR CHEMISTRY, vol. 11, no. 36, 1 January 2013 (2013-01-01), page 6036, XP055762070, ISSN: 1477-0520, DOI: 10.1039/c3ob40900g (B1)
WO-A1-2008/085509 (B1)
WO-A1-2009/126584 (B1)
WO-A1-2010/095767 (B1)
WO-A1-2011/079051 (B1)
WO-A1-2012/091010 (B1)
WO-A1-2012/117027 (B1)
WO-A1-2013/082345 (B1)
WO-A1-2013/130660 (B1)
WO-A1-2013/175417 (B1)
WO-A1-2014/054053 (B1)
WO-A1-2014/133134 (B1)
WO-A1-2014/154586 (B1)
WO-A1-2015/073767 (B1)
WO-A1-2015/112754 (B1)
WO-A1-2015/134699 (B1)
WO-A1-2015/134701 (B1)
WO-A1-2016/044120 (B1)
WO-A1-2016/090382 (B1)
WO-A1-2016/106009 (B1)
WO-A1-2016/121782 (B1)
WO-A1-2017/069224 (B1)
BUSUJIMA, TSUYOSHI et al.: "Identification of 2- [2-(4-tert-butylphenyl)ethyl]-N-(4-fluorop henyl)-1, 2, 3, 4-tetrahydroisoqui noline-6-sulfonamide (29) as an orally available MGAT2 inhibitor", Bioorganic & Medicinal Chemistry, vol. 23, 2015, pages 5922-5931, XP055393280, (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Varsel om betaling av første årsavgift (3319) (PTEP3653625)
|
Utgående
EP Registreringsbrev (3210) (PTEP3653625)
|
Innkommende
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 7. avg. år (EP) | 2024.07.09 | 2860 | CPA GLOBAL LIMITED | Betalt og godkjent |
32402620 expand_more expand_less | 2024.02.26 | 5500 | Novagraaf Brevets | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|